Are you above the legal age to view this content in your province/state?

Home / Cannabis Industry / Recent Survey Finds Many Parkinson’s Disease Patients Turn to Cannabis

Recent Survey Finds Many Parkinson’s Disease Patients Turn to Cannabis

Recent Survey Finds Many Parkinson’s Disease Patients Turn to Cannabis

This story originally appeared on Cannabis and Tech Today.

Parkinson’s disease is a condition that affects populations all over the globe. In fact, it is estimated that over 10 million people live with the condition worldwide.

Parkinson’s disease is a neurodegenerative health condition that affects the nerve cells in the brain that control the body’s movement.

The disease is a progressive condition with the symptoms of Parkinson’s disease increasing gradually as time goes by.

The condition received its name via James Parkinson who is a London doctor that first reported symptoms related to the condition in the early 1800s.

What Are Common Symptoms of Parkinson’s Disease?

One of the hard things about treating Parkinson’s disease is that symptoms vary widely among patients. It’s a condition that seems to affect many patients differently.

Some of the more common symptoms are broken up into two categories – those that affect the patient’s motor function and those that do not.

Common symptoms related to motor function include movement tremors, the ‘freezing’ of physical functions, and rigidity.

Common non-motor function-related symptoms include fatigue/tiredness, depression, and ongoing physical pain.

Symptoms tend to appear more often among people that are 60 years old or older, however, people can develop symptoms earlier in life as well.

Cannabis as a Treatment

Some of the more common pharmaceutical treatments for Parkinson’s disease involve dopamine promoters, pain medications, antidepressants, cognition-enhancing medications, and anti-tremor medications.

Every one of those pharmaceutical drugs come with their own varying levels of side-effects and other potential dangers such as severe addiction.

Cannabis, on the other hand, is not nearly as harmful as the previously mentioned medications, which is likely why more Parkinson’s patients are using the cannabis plant for medical purposes.

A recent survey of Parkinson’s patients found that nearly 1 out of every 4 are using medical cannabis to treat their condition.

The researchers behind the survey are pushing for more research to learn more about best practices when treating Parkinson’s with cannabis, which is an ongoing issue.

“Our results suggest that although there are many people with PD using cannabis as a [complementary alternative] treatment for their motor and non-motor symptoms, the lack of formal guidance about cannabis usage for PD may underlie inconsistencies in use and reported effectiveness,” researchers concluded.


Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.

Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.

Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.

Investment Value Finders is intended for those 21+ years of age only!

Check Also

Cannabis producer Canopy Growth sheds 8% of workforce

Canadian cannabis producer Canopy Growth slashed approximately 8% of its workforce Tuesday as part of …